| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/02/2011 | CA2370187C Treatment of neoplasms with viruses |
| 08/02/2011 | CA2368824C Rapid dehydration of proteins |
| 08/02/2011 | CA2366723C Fatty acid-anticancer conjugates and uses thereof |
| 08/02/2011 | CA2330829C Methods for treating a neurological disease by determining bche genotype |
| 07/28/2011 | WO2011091138A1 Combination therapy to treat autoimmune diseases |
| 07/28/2011 | WO2011090669A1 Methods for treating pain |
| 07/28/2011 | WO2011089265A1 Use of fatty acid compounds for lowering blood glucose levels |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184019 Long chain N-Alkyl compounds and oxa-derivatives thereof |
| 07/28/2011 | US20110183416 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 07/28/2011 | US20110182961 Osteogenic cell delivery matrix |
| 07/28/2011 | US20110182908 Diagnostics and Therapeutics for Macular Degeneration-Related Disorders |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182864 Compositions containing inclusion complexes |
| 07/27/2011 | EP2348134A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348133A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348045A1 Receptor, use of same and murine antibody |
| 07/27/2011 | EP2348032A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/27/2011 | EP2347793A1 Method for regenerating hair follicles by suppressing a gene with hair follicle formation-inhibiting ability or by activating a gene with hair follicle formation - inducing ability |
| 07/27/2011 | EP2347768A1 Novel use application of sugar chain-recognizing receptor |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2347757A1 A natural allicin tablet and preparation method thereof |
| 07/27/2011 | EP2346896A1 Etoposide and doxorubicin conjugates for drug delivery |
| 07/27/2011 | EP2346530A1 Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria |
| 07/27/2011 | EP2346504A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 07/27/2011 | EP2346503A2 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia |
| 07/27/2011 | EP2346502A1 Derivatives of hypoestoxides for the treatment of malaria |
| 07/27/2011 | EP2346499A1 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 07/27/2011 | EP1419152B1 Hiv inhibiting pyrimidines derivatives |
| 07/27/2011 | EP1351694B2 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 07/27/2011 | EP1125585B1 Treatment of graft-versus-host disease targeting ailim |
| 07/27/2011 | EP1071805B1 Adenoviral vectors for treating disease |
| 07/27/2011 | CN1755367B Reagent for detecting sperm membrane surface antigen by immuno-magnetic sand method, its preparation and detection method |
| 07/27/2011 | CN1747744B Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 07/27/2011 | CN1393222B Use of composition of sterol compounds dissolved in oil |
| 07/27/2011 | CN102137682A Anti-hepatitis c virus composition |
| 07/27/2011 | CN102137667A Pharmaceutical composition comprising gaboxadol and an inhibitor of PATL or OAT |
| 07/27/2011 | CN102133407A Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 07/27/2011 | CN102133403A Combined therapy for suppressing tumor growth by using vascular endothelial growth factor (VEGF) receptor antagonist |
| 07/27/2011 | CN102133402A Application of cystic fibrosis transmembrane transduction regulating factor inhibitor to preparation of medicaments for treating diabetes |
| 07/27/2011 | CN102133393A Acidic insulin preparations with improved stability |
| 07/27/2011 | CN102133216A Combined medicine for curing treatment-resistant depression and applications thereof |
| 07/27/2011 | CN102133196A Potassium ion binding polymers for pharmaceutical compositions |
| 07/27/2011 | CN102133180A Long-acting injection preparation of sterides 5 alpha-reductase inhibitor and preparation method thereof |
| 07/27/2011 | CN101394866B Stabilizer for hydrophobic compounds |
| 07/27/2011 | CN101208106B Cancer therapeutic agent |
| 07/27/2011 | CN101052384B Non-aqueous transdermal absorption preparation containing non-steroid antiphlogistic analgesic |
| 07/27/2011 | CN101018567B Induction of apoptosis in Toll-like receptor expressing tumor cells |
| 07/26/2011 | US7985769 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 07/26/2011 | US7985766 anticholinergic glycopyrrolate or salt and long-acting beta 2 sympathomimetic agent selected from formoterol or salmeterol or salts; chronic obstructive pulmonary disease (COPD) and asthma; inhaled |
| 07/26/2011 | US7985587 Methods of culturing dermal papilla cells |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | CA2508611C Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
| 07/26/2011 | CA2505937C Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropaties induced by anticancer agents |
| 07/26/2011 | CA2499814C Strontium compound for treatment of sub-dermal soft tissue pain |
| 07/26/2011 | CA2484482C Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 07/26/2011 | CA2481325C Anti-hiv composition, production method thereof and medicament |
| 07/26/2011 | CA2461941C Anti-irritating rosacea treatment |
| 07/26/2011 | CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization |
| 07/26/2011 | CA2268331C Treatment of inner ear hair cells |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/21/2011 | WO2011088055A2 Methods and compositions for treating cardiovascular disorders |
| 07/21/2011 | WO2011087066A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/21/2011 | WO2011087051A1 Therapeutic agent for atherosclerosis comprising s1p2 receptor antagonist |
| 07/21/2011 | WO2011086470A1 Treatment of multiple sclerosis |
| 07/21/2011 | WO2011085720A1 Biologically active molecules for influencing virus-, bacteria-, parasite-infected cells and/or tumor cells and method for the use thereof |
| 07/21/2011 | US20110178178 Treatment of Motor Fluctuations |
| 07/21/2011 | US20110178160 Inhibition of Interaction of PSD93 and PSDS95 with nNOS and NMDA Receptors |
| 07/21/2011 | US20110178118 Palonosetron for the treatment of chemotherapy induced emeses |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177027 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha |
| 07/21/2011 | DE102010005131A1 Elements comprise on one side, one or more molecules with which they can dock to cancer cells and on other side, one or more molecules as element to be eliminated (e.g. pathogen) with which they are identified by the immune system |
| 07/21/2011 | CA2785970A1 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability |
| 07/20/2011 | EP2345728A1 Yeast membrane protein expression system and its application in drug screening |
| 07/20/2011 | EP2345673A1 Humanized anti-granulocyte MN-3 antibody and uses thereof |
| 07/20/2011 | EP2345424A1 CD4-specific antibody TRX1 and uses therefor |
| 07/20/2011 | EP2345415A1 Therapeutic/prophylactic agent for prostate cancer |
| 07/20/2011 | EP2345412A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 07/20/2011 | EP2344196A1 Carbohydrate binding molecules |
| 07/20/2011 | EP2344195A2 Combination therapy for the treatment of diabetes and related conditions |
| 07/20/2011 | EP2344156A1 Therapeutic combination comprising an aurora kinase inhibitor and an antineoplastic agent |
| 07/20/2011 | EP2344154A1 Compositions that include anthocyanidins and methods of use |
| 07/20/2011 | EP2344146A1 Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs |
| 07/20/2011 | EP2344144A1 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus |
| 07/20/2011 | EP2343963A1 Transdermal delivery |
| 07/20/2011 | EP2168581A9 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 07/20/2011 | EP2139452B1 Polyaphron topical composition with vitamin d and corticosteroid |
| 07/20/2011 | EP1496891B1 Methods for modulating phototoxicity |
| 07/20/2011 | EP1361884B1 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 07/20/2011 | EP1218007B1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 07/20/2011 | EP1181317B1 An integrin heterodimer and an alpha subunit thereof |
| 07/20/2011 | EP1157043B1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 07/20/2011 | CN102131525A Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 07/20/2011 | CN102131504A Combinations comprising bicyclic S1P lyase inhibitors |
| 07/20/2011 | CN102131503A Combination products comprising mGluR modulator for treating parkinson's disease |
| 07/20/2011 | CN102125690A Application of polyphenol components in preparation of medicaments for treating aspirin resistance |
| 07/20/2011 | CN102125689A Compound preparation of proton pump inhibitor and domperidone |